triamcinolone acetonide immediate release (TCA-IR) / Pacira - LARVOL DELTA

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (clinicaltrials.gov) - P2 | N=1 | Terminated | Sponsor: Pacira Pharmaceuticals, Inc | N=32 ➔ 1 | Trial completion date: Apr 2026 ➔ Oct 2025 | Recruiting ➔ Terminated | Trial primary completion date: Apr 2026 ➔ Oct 2025; Study was stopped due to business decision and lack of enrollment. There were no safety concerns.

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Immunology • Osteoarthritis • Pain • Rheumatology

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (clinicaltrials.gov) - P2 | N=32 | Recruiting | Sponsor: Pacira Pharmaceuticals, Inc | Trial completion date: Dec 2025 ➔ Apr 2026 | Trial primary completion date: Dec 2025 ➔ Apr 2026

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology